Evidence map›Paper›PMID 39937313›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025

Survivorship care plan utilization in Australia and New Zealand: survivors', parents' and healthcare providers' perspectives.

Rebecca E Hill, Joanna E Fardell, Rebecca Mercieca-Bebber, Claire E Wakefield, Christina Signorelli, Kate Webber, Karen A Johnston, Richard J Cohn

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. What Matters Most: The Top 10 Child and Adolescent Cancer Research Priorities in Australia.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rebecca E HillSchool of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Randwick, NSW, Australia. r.hill@student.unsw.edu.au.ORCID http://orcid.org/0000-0003-1253-6243
Joanna E FardellSchool of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Randwick, NSW, Australia.ORCID http://orcid.org/0000-0001-7334-3475
Rebecca Mercieca-BebberTrials Centre, NHMRC Clinical, The University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0003-3708-9099
Claire E WakefieldSchool of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Randwick, NSW, Australia.ORCID http://orcid.org/0000-0001-7704-7067
Christina SignorelliSchool of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Randwick, NSW, Australia.ORCID http://orcid.org/0000-0002-7091-0347
Kate WebberSchool of Clinical Sciences at Monash Health, Faculty of Medicine, Monash University, Monash, VIC, Australia.ORCID http://orcid.org/0000-0003-4350-0884
Karen A JohnstonSchool of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Randwick, NSW, Australia.
Richard J CohnSchool of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Randwick, NSW, Australia.ORCID http://orcid.org/0000-0002-2400-1353

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAs part of survivorship care, many health authorities recommend survivorship care plans (SCPs). The aim of this study was to understand survivors' SCP receipt and use, clinical/demographic factors associated with use, and providers' SCP practices.

methodsWe surveyed Australian and New Zealand survivors of adult and childhood cancer (including parent proxies for survivors aged < 16 years). We fitted binomial logistic regression models to examine the relationship between survivors' clinical and sociodemographic characteristics, and SCP receipt. We also surveyed oncology health providers regarding current SCP provision practices, perceived receipt, and usefulness.

resultsWe recruited 1123 cancer survivors (499 adult cancer survivors and 624 childhood cancer survivors, including 222 parent proxies) and 21 healthcare providers. 10.7% of adult and 22.0% of childhood cancer survivors recalled receiving SCPs. SCP receipt was more likely for adult cancer survivors diagnosed with prostate cancer, low-risk cancer diagnoses and older at study participation, and childhood cancer survivors treated with chemotherapy or younger at study participation. Across both groups, a higher level of education attainment was predictive of SCP use. Most healthcare providers estimated that < 15% of adult and > 75% of childhood cancer survivors received SCPs.

conclusionsFew survivors of adult or childhood cancer reported receiving a SCP, and there were sociodemographic and clinical differences in those who did and did not receive and use their SCP. SCP recipients used and valued them, but healthcare providers indicated potential areas for improvement with SCP provision. Consideration may be needed regarding SCP format, presentation and content.

Indexed as

Cancer SurvivorsHealth PersonnelNeoplasmsParentsPatient Care PlanningSurvivorshipAdolescentAdultAgedAge FactorsAustraliaChildFemaleHumansMaleMiddle AgedCancerSurvivorSurvivorshipSurvivorship care plansTreatment summary

Identifiers

PMID39937313
PMCPMC11821783

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.